Owen Carolyn, Banerji Versha, Johnson Nathalie, Gerrie Alina, Aw Andrew, Chen Christine, Robinson Sue
Division of Hematology and Hematological Malignancies, Foothills Medical Centre, Calgary, AB T2N 4N2, Canada.
Department of Hematology and Medical Oncology, CancerCare Manitoba, Winnipeg, MB R3E 0V9, Canada.
Leuk Res. 2023 Feb;125:107016. doi: 10.1016/j.leukres.2023.107016. Epub 2023 Jan 5.
Chronic lymphocytic leukemia (cll) is the most common adult leukemia in North America. In 2018, the first unified national guideline in Canada was developed for the front-line treatment of cll that helped guide treatment across the country. As an update in 2022, a group of clinical experts from across Canada came together to provide input and guidance that included new and innovative treatments and approaches that will continue to provide health care professionals with clear guidance on the first-line management of cll. Recommendations were provided in consensus based on available evidence for the first-line treatment of cll.
慢性淋巴细胞白血病（CLL）是北美最常见的成人白血病。2018年，加拿大制定了首个针对CLL一线治疗的全国统一指南，该指南有助于指导全国范围内的治疗。作为2022年的更新内容，来自加拿大各地的一组临床专家齐聚一堂，提供包括新的和创新的治疗方法及途径等方面的意见和指导，这将继续为医疗保健专业人员在CLL一线管理方面提供明确的指导。基于现有证据，就CLL一线治疗达成了共识并给出了建议。
